Treatment outcome in patients with triple negative early stage breast cancers compared with other molecular subtypes
Radiation Oncology Journal. 2012;30(3):124 
Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies
The Breast. 2019;44:S27
Outcome After Breast Conservation Treatment with Radiation for Women with Triple-Negative Early-Stage Invasive Breast Carcinoma
Clinical Breast Cancer. 2009;9(2):96-100
Early Stage Triple Negative and HER2 Overexpression Breast Cancers Have Similar Survivals in Chinese Patients
The Breast Journal. 2012;18(3):286-288
Cisplatin–gemcitabine therapy in metastatic breast cancer: Improved outcome in triple negative breast cancer patients compared to non-triple negative patients
The Breast. 2010;19(3):246-248
Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which Is Worst?
Annals of Surgical Oncology. 2021;
Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes
Cancers. 2020;12(4):819
Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
Cancers. 2020;12(6):1404
PG 12.01 Tailoring the chemotherapy regimen in patients with triple negative subtypes
The Breast. 2015;24:S22
Assessment of Suspected Breast Lesions in Early Stage Triple Negative Breast Cancer During Follow-up After Breast Conserving Surgery Using Multiparmetric MRI
. 2020;